Genomic assays for Epstein–Barr virus-positive gastric adenocarcinoma

  • Margaret L Gulley
  • Published 2015 in Experimental & Molecular Medicine


A small set of gastric adenocarcinomas (9%) harbor Epstein–Barr virus (EBV) DNA within malignant cells, and the virus is not an innocent bystander but rather is intimately linked to pathogenesis and tumor maintenance. Evidence comes from unique genomic features of host DNA, mRNA, microRNA and CpG methylation profiles as revealed by recent comprehensive… (More)
DOI: 10.1038/emm.2014.93


9 Figures and Tables

Cite this paper

@inproceedings{Gulley2015GenomicAF, title={Genomic assays for Epstein–Barr virus-positive gastric adenocarcinoma}, author={Margaret L Gulley}, booktitle={Experimental & Molecular Medicine}, year={2015} }